IBEX Ltd (IBEX) Stock Analysis and Metrics

Ibex

NASDAQ: IBEX

$33.42 ▲ +1.22 (+3.77%)

At close: Jul 24, 2026 · 3:59 PM UTC

Financial Ratios

Market Cap433.35 Mn

P/E9.18

P/S0.69

Div. Yield0.00

ROIC (Qtr)0.04

Total Debt (Qtr)1.39 Mn

Revenue Growth (1y) (Qtr)16.82

Add ratio to table…

About

ibex delivers innovative business process outsourcing, smart digital marketing, online acquisition technology, and end to end customer engagement solutions to help companies acquire, engage, and retain valuable customers. The company combines its heritage in customer experience operations with a proprietary technology platform to provide omnichannel support, technical assistance, revenue generation, and back office services across voice, email, chat, SMS, and social media channels.

ibex generates revenue principally from its Connect business, which provides customer service, technical support, upselling and cross selling, and outsourced back office functions such as finance and accounting, marketing support, sales operations, and human resources administration. Additional revenue comes from the ibex Digital suite, offering digital marketing, e commerce technology, and platform solutions, and from the CX services segment, which measures, monitors, and manages holistic customer experiences for clients. The company serves a diversified client base that includes high growth digital first firms and established Fortune 500 blue chip companies across retail, e commerce, health technology, fintech, telecommunications, travel, transportation, logistics, and technology verticals.

The company operates through the following segments.

• Connect: This segment delivers differentiated customer service, technical support, revenue generation through upselling and cross selling, and value added outsourced back office services such as finance and accounting, marketing support, sales operations, and human resources administration via an omnichannel model integrating voice, email, chat, SMS, and social media.

• ibex Digital: This segment provides digital marketing, e commerce technology, and platform solutions that help consumer facing businesses build, grow, and scale technology driven customer acquisition channels while supporting digital transformation.

• ibex CX: This segment offers a suite of customer experience services that measure, monitor, and manage clients holistic customer experiences through analytics, surveys, and insight generation.

ibex positions itself as a technology led BPO 2.0 provider competing against traditional outsourcing firms and in house customer service departments by offering an integrated end to end customer lifecycle experience platform. Its competitive advantages include the proprietary Wave iX technology platform with AI powered virtual agent and translation capabilities, a strong agent first culture reflected in an employee Net Promoter Score of 77, and a flexible global delivery model spanning onshore, nearshore, offshore, and work at home locations. These differentiators enable ibex to attract both high growth digital first disruptors and established blue chip clients seeking enhanced brand loyalty and customer lifetime value.

ibex serves a varied clientele that includes digital first companies such as Amazon and a leading U. S. ride sharing firm, as well as blue chip enterprises exemplified by Philippine Airlines and numerous Fortune 500 organizations in telecommunications, financial services, healthcare, and technology.

Investment Thesis

▲ Bull case

IBEX Limited shows strong structural growth driven by high margin verticals such as health tech and technology which expanded to 20.8% and 9.2% of revenue respectively in the quarter. This shift reflects a deliberate move away from low margin telecommunications which fell to 8.6% of revenue. The company is capturing market share from larger competitors while maintaining near perfect client retention at 99.9% for the year. These trends indicate that the revenue base is becoming more resilient and less cyclical. The continued addition of new logos especially in health care suggests that the growth runway extends well beyond the current fiscal year. The management team has demonstrated the ability to build and scale new verticals from the ground up as evidenced by the health tech segment that launched in 2021 and now exceeds a $100 million run rate.
The partnership with Sierra AI provides a clear path to margin expansion by layering technology software style economics onto the existing BPO platform. Management indicated that the AI agent contracts will be billed under IBEX Limited contracts and will generate gross margins in the 30% range which is significantly higher than traditional BPO margins. Early wins with a leading airline demonstrated that the combined solution can be deployed in weeks and deliver containment results that exceed benchmarks before competitors even go live. This speed to market creates a competitive moat that is difficult for pure play AI vendors or legacy BPO firms to replicate. The ability to offer both AI driven automation and high touch human support positions IBEX Limited as a full stack provider in the emerging BPO 3.0 landscape. As more clients seek partners that can bridge the gap between autonomous agents and human expertise the company is likely to capture a disproportionate share of incremental spending.
Operating leverage is improving as SG&A expenses fell from 19.2% to 16.7% of revenue reflecting disciplined cost control while revenue continues to grow at double digit rates. This combination of top line expansion and bottom line efficiency is driving free cash flow generation which rose to $6.6 million in the quarter up from $3.6 million a year ago. Strong cash conversion enables the company to fund internal investments such as the increased capital expenditure guidance of $25 million to $30 million for the full year without relying on external financing. The net cash position of approximately $14 million provides a buffer that can be used to pursue strategic acquisitions or to weather any short term macroeconomic headwinds. The balance sheet strength also supports the ongoing share repurchase program which returned $4.5 million to shareholders in the quarter. Overall the financial profile is shifting from a pure growth story to one that includes sustainable cash generation and shareholder returns.
Client diversification metrics show that the largest account represents only 9% of revenue and the top ten clients grew 19.3% year over year indicating that growth is broad based and not reliant on a single mega client. The company added nearly 20% more clients that exceed $1 million in annual revenue bringing the total to 70 such accounts which demonstrates success in scaling meaningful relationships. Revenue retention of 99.9% for the year and 100% retention for the quarter underscores the stickiness of the offering and the depth of client relationships. This low churn environment reduces the need for costly replacement efforts and allows the sales organization to focus on upsell and cross sell opportunities. The ability to win new logos while retaining existing ones creates a virtuous flywheel that fuels continued expansion. As the flywheel accelerates the company is likely to outpace the growth rates of traditional BPO peers that lack comparable diversification.
The health tech vertical is not a temporary boom but a sustainable new run rate as confirmed by the CFO who stated that none of the revenue was one time in nature. Vertical growth of 53.7% year over year has pushed the segment to 20.8% of total revenue and the trend is supported by the addition of six new logos in the health care space over the last two years. This expansion is being driven by taking market share from large payers with budgets north of $600 million which provides a deep pipeline of opportunities. The company has successfully transformed its U S business from a low margin legacy telecom focus to a high margin health care delivery model which is reflected in both top line and bottom line improvements. The structural nature of this shift means that the health tech contribution is likely to persist and grow as the vertical matures.

IBEX Limited shows strong structural growth driven by high margin verticals such as health tech and technology which expanded to 20.8% and 9.2% of revenue respectively in the quarter. This shift reflects a deliberate move away from low margin telecommunications which fell to 8.6% of revenue. The company is capturing market share from larger competitors while maintaining near perfect client retention at 99.9% for the year. These trends indicate that the revenue base is becoming more resilient and less cyclical. The continued addition of new logos especially in health care suggests that the growth runway extends well beyond the current fiscal year. The management team has demonstrated the ability to build and scale new verticals from the ground up as evidenced by the health tech segment that launched in 2021 and now exceeds a $100 million run rate.
The partnership with Sierra AI provides a clear path to margin expansion by layering technology software style economics onto the existing BPO platform. Management indicated that the AI agent contracts will be billed under IBEX Limited contracts and will generate gross margins in the 30% range which is significantly higher than traditional BPO margins. Early wins with a leading airline demonstrated that the combined solution can be deployed in weeks and deliver containment results that exceed benchmarks before competitors even go live. This speed to market creates a competitive moat that is difficult for pure play AI vendors or legacy BPO firms to replicate. The ability to offer both AI driven automation and high touch human support positions IBEX Limited as a full stack provider in the emerging BPO 3.0 landscape. As more clients seek partners that can bridge the gap between autonomous agents and human expertise the company is likely to capture a disproportionate share of incremental spending.
Operating leverage is improving as SG&A expenses fell from 19.2% to 16.7% of revenue reflecting disciplined cost control while revenue continues to grow at double digit rates. This combination of top line expansion and bottom line efficiency is driving free cash flow generation which rose to $6.6 million in the quarter up from $3.6 million a year ago. Strong cash conversion enables the company to fund internal investments such as the increased capital expenditure guidance of $25 million to $30 million for the full year without relying on external financing. The net cash position of approximately $14 million provides a buffer that can be used to pursue strategic acquisitions or to weather any short term macroeconomic headwinds. The balance sheet strength also supports the ongoing share repurchase program which returned $4.5 million to shareholders in the quarter. Overall the financial profile is shifting from a pure growth story to one that includes sustainable cash generation and shareholder returns.
Client diversification metrics show that the largest account represents only 9% of revenue and the top ten clients grew 19.3% year over year indicating that growth is broad based and not reliant on a single mega client. The company added nearly 20% more clients that exceed $1 million in annual revenue bringing the total to 70 such accounts which demonstrates success in scaling meaningful relationships. Revenue retention of 99.9% for the year and 100% retention for the quarter underscores the stickiness of the offering and the depth of client relationships. This low churn environment reduces the need for costly replacement efforts and allows the sales organization to focus on upsell and cross sell opportunities. The ability to win new logos while retaining existing ones creates a virtuous flywheel that fuels continued expansion. As the flywheel accelerates the company is likely to outpace the growth rates of traditional BPO peers that lack comparable diversification.
The health tech vertical is not a temporary boom but a sustainable new run rate as confirmed by the CFO who stated that none of the revenue was one time in nature. Vertical growth of 53.7% year over year has pushed the segment to 20.8% of total revenue and the trend is supported by the addition of six new logos in the health care space over the last two years. This expansion is being driven by taking market share from large payers with budgets north of $600 million which provides a deep pipeline of opportunities. The company has successfully transformed its U S business from a low margin legacy telecom focus to a high margin health care delivery model which is reflected in both top line and bottom line improvements. The structural nature of this shift means that the health tech contribution is likely to persist and grow as the vertical matures.

▼ Bear case

Telecommunications vertical continues to deteriorate representing a structural decline that could weigh on overall revenue mix. The segment fell 23.1% year over year and now accounts for only 8.6% of revenue. Legacy carrier volume loss appears to be a long term trend rather than a cyclical dip. This ongoing erosion reduces the diversity of the revenue base and may force the company to rely more heavily on high growth verticals to sustain overall growth. If the high growth verticals fail to maintain their current pace the overall topline could stagnate. The company has acknowledged that the shift will cause an additional asset impairment charge in the fourth quarter as capacity is adjusted.
AI driven displacement of human agent volumes could outpace the company ability to monetize the new technology leading to revenue volatility. Management admitted that the AI solution will cannibalize some of the existing business as human volume gets displaced by AI. While they expect net accretive impact the timing and magnitude of the AI revenue ramp remain uncertain. If AI containment improves faster than anticipated the reduction in human assisted interactions could exceed the growth from AI led solutions. This mismatch could pressure margins especially if the AI contracts do not achieve the promised 30% gross margin. The early wins are encouraging but they represent a small fraction of the total addressable market and may not be scalable at the same speed.
The company dependence on the health tech vertical introduces concentration risk despite overall client diversification. Health tech grew 53.7% year over year and now represents 20.8% of revenue making it the single largest vertical. A slowdown in health care spending or a loss of market share to competitors could disproportionately affect overall performance. The CFO emphasized that the health tech revenue is sustainable but the vertical is still relatively nascent and may be subject to regulatory changes or shifts in payer priorities. Any adverse development in the health care sector could have an outsized impact on earnings. The company would then need to rely on other verticals that are growing at slower rates to fill the gap.
Integration of the Sierra AI partnership presents execution risk that could delay the anticipated margin benefits. The management team acknowledged they are partnering because they could not build a best in class AI engine themselves. Relying on an external provider introduces dependencies on Sierra’s roadmap pricing and support capabilities. Any misalignment in product development timelines or commercial terms could slow down the rollout of AI powered solutions. The company also needs to train its workforce to effectively sell and deliver the new technology which may incur additional costs and reduce short term profitability. If the integration takes longer than expected the upward guidance revisions may prove overly optimistic.
Macroeconomic headwinds could disproportionately affect the company discretionary spending clients especially in retail and travel verticals. Retail and ecommerce grew only 8.3% year over year and travel transportation and logistics grew 15.1% which are modest compared to the high flying health tech and technology segments. A slowdown in consumer spending or a reduction in corporate travel budgets could curb demand for these services. The company offshore model which relies on labor cost advantages may face pressure if wage inflation in key delivery locations erodes margin benefits. Additionally a stronger U S dollar could make offshore delivery less cost competitive for clients that are sensitive to price. These external factors could limit the ability to sustain double digit revenue growth.

Telecommunications vertical continues to deteriorate representing a structural decline that could weigh on overall revenue mix. The segment fell 23.1% year over year and now accounts for only 8.6% of revenue. Legacy carrier volume loss appears to be a long term trend rather than a cyclical dip. This ongoing erosion reduces the diversity of the revenue base and may force the company to rely more heavily on high growth verticals to sustain overall growth. If the high growth verticals fail to maintain their current pace the overall topline could stagnate. The company has acknowledged that the shift will cause an additional asset impairment charge in the fourth quarter as capacity is adjusted.
AI driven displacement of human agent volumes could outpace the company ability to monetize the new technology leading to revenue volatility. Management admitted that the AI solution will cannibalize some of the existing business as human volume gets displaced by AI. While they expect net accretive impact the timing and magnitude of the AI revenue ramp remain uncertain. If AI containment improves faster than anticipated the reduction in human assisted interactions could exceed the growth from AI led solutions. This mismatch could pressure margins especially if the AI contracts do not achieve the promised 30% gross margin. The early wins are encouraging but they represent a small fraction of the total addressable market and may not be scalable at the same speed.
The company dependence on the health tech vertical introduces concentration risk despite overall client diversification. Health tech grew 53.7% year over year and now represents 20.8% of revenue making it the single largest vertical. A slowdown in health care spending or a loss of market share to competitors could disproportionately affect overall performance. The CFO emphasized that the health tech revenue is sustainable but the vertical is still relatively nascent and may be subject to regulatory changes or shifts in payer priorities. Any adverse development in the health care sector could have an outsized impact on earnings. The company would then need to rely on other verticals that are growing at slower rates to fill the gap.
Integration of the Sierra AI partnership presents execution risk that could delay the anticipated margin benefits. The management team acknowledged they are partnering because they could not build a best in class AI engine themselves. Relying on an external provider introduces dependencies on Sierra’s roadmap pricing and support capabilities. Any misalignment in product development timelines or commercial terms could slow down the rollout of AI powered solutions. The company also needs to train its workforce to effectively sell and deliver the new technology which may incur additional costs and reduce short term profitability. If the integration takes longer than expected the upward guidance revisions may prove overly optimistic.
Macroeconomic headwinds could disproportionately affect the company discretionary spending clients especially in retail and travel verticals. Retail and ecommerce grew only 8.3% year over year and travel transportation and logistics grew 15.1% which are modest compared to the high flying health tech and technology segments. A slowdown in consumer spending or a reduction in corporate travel budgets could curb demand for these services. The company offshore model which relies on labor cost advantages may face pressure if wage inflation in key delivery locations erodes margin benefits. Additionally a stronger U S dollar could make offshore delivery less cost competitive for clients that are sensitive to price. These external factors could limit the ability to sustain double digit revenue growth.

Timing of Transfer of Good or Service Breakdown of Revenue (2025)

Peer Comparison

Companies in the Information Technology Services

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	IBM	International Business Machines Corp	193.88 Bn	8,812.83	2.81	61.99 Bn
2	ACN	Accenture plc	84.94 Bn	10.70	1.16	5.14 Bn
3	GDS	GDS Holdings Ltd	50.55 Bn	126.44	29.45	-
4	INFY	Infosys Ltd	44.05 Bn	0.29	0.05	-
5	GIB	Cgi Inc	41.25 Bn	0.32	3.47	2.65 Bn
6	FIS	Fidelity National Information Services, Inc.	20.63 Bn	134.81	1.80	16.99 Bn
7	CTSH	Cognizant Technology Solutions Corp	20.39 Bn	9.24	0.95	0.57 Bn
8	WIT	Wipro Ltd	18.65 Bn	12.56	1.80	1.88 Bn

Research Tools

Developers

About

Investment Thesis

Geographical Breakdown of Revenue (2025)

Timing of Transfer of Good or Service Breakdown of Revenue (2025)

Peer Comparison

Research Tools

Developers

About

Investment Thesis

Geographical Breakdown of Revenue (2025)

Timing of Transfer of Good or Service Breakdown of Revenue (2025)

Peer Comparison

Create an account

Sign In

Reset Password